Atomoxetine: all 143 studies that test it
Page 2 of 2. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHDCompletedNCT00486083Phase 3
- Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHDCompletedNCT00485875Phase 4
- A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASDCompletedNCT00485849Phase 4
- Safety Study in Outpatient Japanese Children With ADHDCompletedNCT00485628Phase 2
- Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant TherapyCompletedNCT00485550Phase 3
- Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHDCompletedNCT00485459Phase 3
- Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of AtomoxetineCompletedNCT00485407Phase 3
- Effects of Atomoxetine on Cognitive Function in SchizophreniaCompletedNCT00420498Phase 2
- Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHDCompletedNCT00417794Phase 1
- Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity DisorderCompletedNCT00386581Phase 3
- Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim PrisonCompletedNCT00356070Not applicable
- Atomoxetine in the Treatment of Binge Eating DisorderCompletedNCT00327834Phase 4
- Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALLTerminatedNCT00299234Phase 4
- Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1CompletedNCT00265265Phase 1
- Treatment of Orthostatic IntoleranceActive, not recruitingNCT00262470Phase 1/2
- Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late EffectsWithdrawnNCT00255138Phase 3
- Effect of Atomoxetine on ADHD-Related Insomnia in Children and AdolescentsStatus unknownNCT00252278Phase 4
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
- A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With SchizophreniaCompletedNCT00222794Phase 4
- Effectiveness of ATMX in Treating Adolescents With ADHD and SUDCompletedNCT00218322Phase 4
- Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.CompletedNCT00216918Phase 4
- Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity DisorderCompletedNCT00191880Phase 3
- An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity DisorderCompletedNCT00191737Phase 3
- Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODDCompletedNCT00191698Phase 3
- Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/AdolescentsCompletedNCT00191659Phase 3
- Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional OutcomesCompletedNCT00191633Phase 4
- Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and AdolescentsCompletedNCT00191542Phase 3
- An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity DisorderCompletedNCT00191516Phase 3
- Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00191295Phase 2/3
- Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHDCompletedNCT00191048Phase 4
- Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHDCompletedNCT00191035Phase 4
- Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's DiseaseCompletedNCT00191009Phase 2/3
- Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol AbuseCompletedNCT00190957Phase 4
- A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity DisorderCompletedNCT00190931Phase 4
- Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety DisorderCompletedNCT00190879Phase 4
- Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)CompletedNCT00190736Phase 4
- Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant TherapyCompletedNCT00181948Phase 4
- Concerta Treatment in Adults With ADHD NOSCompletedNCT00181740Phase 4
- Treatment of Adult ADHD With Atomoxetine or Atomoxetine and BusparCompletedNCT00174226Phase 2
- Atomoxetine for the Treatment of Cannabis DependenceCompletedNCT00167297Phase 2
- Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of SchizophreniaCompletedNCT00161031Not applicable
- Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity DisorderCompletedNCT00142961Phase 2
- Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHDCompletedNCT00029614Phase 2